 Home > Active Ingredient News > Blood System > NEJM: Autologous lentiviral gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency

NEJM: Autologous lentiviral gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency

 Last Update: 2021-06-01
 Source: Internet
 Author: User

Tags

ada 2

breaking therapy

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Severe combined immunodeficiency (ADA-SCID) caused by adenosine deaminase (ADA) deficiency is a rare and life-threatening primary immunodeficiency.

Immune infection recently researchers examined the therapeutic effect of autologous in vitro lentiviral gene therapy for ADA-SCID is.

Fifty ADA-SCID patients (30 from the United States and 20 from the United Kingdom) participated in the study, using autologous CD34+ hematopoietic stem and progenitor cells (HSPCs) to transduce a self-inactivating lentiviral vector encoding human ADA in vitro , The study was followed up for 24-36 months.

stem cell

During the follow-up, the overall survival rate of the patients was 100% .

The overall survival rate of patients was 100% .

Event-free survival rate of patients in the UK and US cohorts

Isolated lentiviral HSPC gene therapy can treat severe combined immunodeficiency caused by adenosine deaminase deficiency.

Original source:

Donald B.

Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.

Leave a message here

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.